0001068238-19-000023.txt : 20190201 0001068238-19-000023.hdr.sgml : 20190201 20190201120649 ACCESSION NUMBER: 0001068238-19-000023 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190201 DATE AS OF CHANGE: 20190201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RUSNANO CENTRAL INDEX KEY: 0001548606 IRS NUMBER: 000000000 STATE OF INCORPORATION: 1Z FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90812 FILM NUMBER: 19558581 BUSINESS ADDRESS: STREET 1: 10A 60-LETIYA OKTYABRYA PROSPECT CITY: MOSCOW STATE: 1Z ZIP: 117036 BUSINESS PHONE: 495-988-5388 MAIL ADDRESS: STREET 1: 10A 60-LETIYA OKTYABRYA PROSPECT CITY: MOSCOW STATE: 1Z ZIP: 117036 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RUSNANO CENTRAL INDEX KEY: 0001548606 IRS NUMBER: 000000000 STATE OF INCORPORATION: 1Z FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 10A 60-LETIYA OKTYABRYA PROSPECT CITY: MOSCOW STATE: 1Z ZIP: 117036 BUSINESS PHONE: 495-988-5388 MAIL ADDRESS: STREET 1: 10A 60-LETIYA OKTYABRYA PROSPECT CITY: MOSCOW STATE: 1Z ZIP: 117036 SC 13G/A 1 selecta_biosciences-sch13ga.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Selecta Biosciences, Inc.
(Name of Issuer)
 
Common Stock, $0.0001 par value
(Title of Class of Securities)
 
816212104
(CUSIP Number)
 
December 31, 2018
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐   Rule 13d-1(b)

⌧  Rule 13d-1(c)

☐   Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


1



CUSIP No.
816212104

1
NAMES OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
 
 RUSNANO
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 Russian Federation
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
 810,665
 
 
 
 
6
SHARED VOTING POWER
 
 
 0
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
 810,665
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
 0
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 810,665
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
 3.6%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
 CO
 
 
 
 




2



Item 1.
 
   
(a)
Name of Issuer: Selecta Biosciences, Inc.
   
(b)
Address of Issuer’s Principal Executive Offices:  480 Arsenal Way, Watertown, MA 02472
   
Item 2.
   
     
(a)  
Name of Person Filing: RUSNANO
(b)  
Address of Principal Business Office or, if None, Residence:  10A prospect 60-letiya Oktyabrya, 117036, Moscow, Russian Federation
(c)  
Citizenship:  Russian Federation
(d)  
Title and Class of Securities: Common Stock, $0.0001 par value per share
(e)  
CUSIP No.:  816212104
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
 
(a)
Broker or dealer registered under Section 15 of the Act;
       
 
(b)
Bank as defined in Section 3(a)(6) of the Act;
       
 
(c)
Insurance company as defined in Section 3(a)(19) of the Act;
       
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940;
       
  (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       
  (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       
  (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________



3


Item 4.
Ownership
   
(a)
Amount Beneficially Owned:   810,665
   
(b)
Percent of Class:  3.6%
   
(c)
Number of shares as to which such person has:
   
 
(i)
Sole power to vote or to direct the vote: 810,665
     
 
(ii)
Shared power to vote or to direct the vote: 0
     
 
(iii)
Sole power to dispose or to direct the disposition of: 810,665
     
 
(iv)
Shared power to dispose or to direct the disposition of: 0
     
Item 5.
Ownership of Five Percent or Less of a Class.
   
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .
   
Item 6.
Ownership of more than Five Percent on Behalf of Another Person.
   
Not applicable.
 
Item 7.
Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.
   
Not applicable.
 
Item 8.
Identification and classification of members of the group.
   
Not applicable.
 
Item 9.
Notice of Dissolution of Group.
   
Not applicable.
 
Item 10.
Certifications.
   
4

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated:  February 1, 2019

_____________
Yury Udaltsov, Deputy Chairman of the Management Board of Management Company RUSNANO LLC
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).


  RUSNANO
 
       
Date
By:
/s/ Yury Udaltsov
 
    Name: Yury Udaltsov
 
    Title:    Deputy Chairman of the Management Board of Management Company RUSNANO LLC  
       



5